These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

123 related items for PubMed ID: 9678107

  • 1. Effects of two combined monophasic and triphasic ethinylestradiol/gestodene oral contraceptives on natural inhibitors and other hemostatic variables.
    Creatsas G, Kontopoulou-Griva I, Deligeoroglou E, Digenopoulou L, Tsangaris A, Kallipolitis G, Milingos S, Michalas S.
    Eur J Contracept Reprod Health Care; 1997 Mar; 2(1):31-8. PubMed ID: 9678107
    [Abstract] [Full Text] [Related]

  • 2. A comparative study of the effects of the hemostatic system of two monophasic gestodene oral contraceptives containing 20 micrograms and 30 micrograms ethinylestradiol.
    Winkler UH, Schindler AE, Endrikat J, Düsterberg B.
    Contraception; 1996 Feb; 53(2):75-84. PubMed ID: 8838483
    [Abstract] [Full Text] [Related]

  • 3. Ethinylestradiol 20 versus 30 micrograms combined with 150 micrograms desogestrel: a large comparative study of the effects of two low-dose oral contraceptives on the hemostatic system.
    Winkler UH, Hölscher T, Schulte H, Zierleyn JP, Collet W, Schindler AE.
    Gynecol Endocrinol; 1996 Aug; 10(4):265-71. PubMed ID: 8908527
    [Abstract] [Full Text] [Related]

  • 4. The effect of oestrogen dose and progestogen type on haemostatic changes in women taking low dose oral contraceptives.
    Norris LA, Bonnar J.
    Br J Obstet Gynaecol; 1996 Mar; 103(3):261-7. PubMed ID: 8630312
    [Abstract] [Full Text] [Related]

  • 5. Efficacy and acceptability of two monophasic oral contraceptives containing ethinylestradiol and either desogestrel or gestodene.
    Halbe HW, de Melo NR, Bahamondes L, Petracco A, Lemgruber M, de Andrade RP, da Cunha DC, Guazelli CA, Baracat EC.
    Eur J Contracept Reprod Health Care; 1998 Sep; 3(3):113-20. PubMed ID: 9853201
    [Abstract] [Full Text] [Related]

  • 6. Changes in coagulation and anticoagulation in women taking low-dose triphasic oral contraceptives: a controlled comparative 12-month clinical trial.
    Notelovitz M, Kitchens CS, Khan FY.
    Am J Obstet Gynecol; 1992 Nov; 167(5):1255-61. PubMed ID: 1442974
    [Abstract] [Full Text] [Related]

  • 7. Effects of monophasic low-dose oral contraceptives on fibrin formation and resolution in young women.
    Petersen KR, Sidelmann J, Skouby SO, Jespersen J.
    Am J Obstet Gynecol; 1993 Jan; 168(1 Pt 1):32-8. PubMed ID: 8420344
    [Abstract] [Full Text] [Related]

  • 8. Blood coagulation with a combination pill containing gestodene and ethinyl estradiol.
    Bonnar J, Daly L, Carroll E.
    Int J Fertil; 1987 Jan; 32 Suppl():21-8. PubMed ID: 2906344
    [Abstract] [Full Text] [Related]

  • 9. Effect of two low-dose gestodene containing monophasic oral contraceptives on hemostasis in Bulgarian women.
    Uchikova E, Pehlivanov B.
    Expert Opin Pharmacother; 2008 Aug; 9(11):1839-44. PubMed ID: 18627323
    [Abstract] [Full Text] [Related]

  • 10. A comparative study on the effects of a monophasic pill containing desogestrel plus 20 micrograms ethinylestradiol, a triphasic combination containing levonorgestrel and a monophasic combination containing gestodene on coagulatory factors.
    Melis GB, Fruzzetti F, Nicoletti I, Ricci C, Lammers P, Atsma WJ, Fioretti P.
    Contraception; 1991 Jan; 43(1):23-31. PubMed ID: 1825970
    [Abstract] [Full Text] [Related]

  • 11. Effects on hemostasis after two-year use of low dose combined oral contraceptives with gestodene or levonorgestrel.
    Prasad RN, Koh SC, Viegas OA, Ratnam SS.
    Clin Appl Thromb Hemost; 1999 Jan; 5(1):60-70. PubMed ID: 10725985
    [Abstract] [Full Text] [Related]

  • 12. Effects of two oral contraceptives, containing 30 or 20 microg of ethinyl estradiol in combination with gestodene, on blood coagulation and fibrinolysis in Brazilian women.
    Ferreira AC, Montes MB, Franceschini SA, Toloi MR.
    Int J Fertil Womens Med; 2001 Jan; 46(5):265-70. PubMed ID: 11720199
    [Abstract] [Full Text] [Related]

  • 13. Effects of long-term gestodene-containing oral contraceptive administration on hemostasis.
    Abbate R, Pinto S, Rostagno C, Bruni V, Rosati D, Mariani G.
    Am J Obstet Gynecol; 1990 Jul; 163(1 Pt 2):424-9. PubMed ID: 2372036
    [Abstract] [Full Text] [Related]

  • 14. The effects of a low-dose gestodene-containing oral contraceptive on endometrial histology in healthy women.
    Coenen CM, Hollanders JM, Rolland R, Spielmann D, Bulten J.
    Eur J Contracept Reprod Health Care; 1996 Dec; 1(4):325-9. PubMed ID: 9678115
    [Abstract] [Full Text] [Related]

  • 15. Hemostatic system changes induced by 50 micrograms and 30 micrograms estrogen/progestogen oral contraceptives. Modification of estrogen effects by levonorgestrel.
    Sabra A, Bonnar J.
    J Reprod Med; 1983 Jan; 28(1 Suppl):85-91. PubMed ID: 6834350
    [Abstract] [Full Text] [Related]

  • 16. Body weight change during use of a monophasic oral contraceptive containing 20 microg ethinylestradiol and 75 microg gestodene with a comparison of the women who completed versus those who prematurely discontinued intake.
    Endrikat J, Gerlinger C, Cronin M, Wessel J, Ruebig A, Rosenbaum P, Düsterberg B.
    Eur J Contracept Reprod Health Care; 2001 Dec; 6(4):199-204. PubMed ID: 11848649
    [Abstract] [Full Text] [Related]

  • 17. [Hemostatic balance during treatment with the newest contraceptives].
    Petersen KR, Skouby SO, Sidelmann J, Jespersen J.
    Ugeskr Laeger; 1994 Jan 10; 156(2):187-90. PubMed ID: 8296409
    [Abstract] [Full Text] [Related]

  • 18. Inhibition of follicular growth by two different oral contraceptives (monophasic and triphasic) containing ethinylestradiol and gestodene.
    Lete I, Morales P.
    Eur J Contracept Reprod Health Care; 1997 Sep 10; 2(3):187-91. PubMed ID: 9678091
    [Abstract] [Full Text] [Related]

  • 19. A comparison of the effects of two triphasic oral contraceptives on haemostasis.
    Cohen H, Mackie IJ, Walshe K, Gillmer MD, Machin SJ.
    Br J Haematol; 1988 Jun 10; 69(2):259-63. PubMed ID: 3390394
    [Abstract] [Full Text] [Related]

  • 20. Metabolic profile of six oral contraceptives containing norgestimate, gestodene, and desogestrel.
    Teichmann A.
    Int J Fertil Menopausal Stud; 1995 Jun 10; 40 Suppl 2():98-104. PubMed ID: 8574257
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.